UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050829
Receipt number R000052335
Scientific Title Prevention of pneumonia in stroke patients
Date of disclosure of the study information 2023/04/13
Last modified on 2023/10/31 12:04:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory study of prevention of pneumonia by positional adjustment in acute stroke patients at Hospital A

Acronym

Prevention of pneumonia by positional adjustment in acute stroke patients

Scientific Title

Prevention of pneumonia in stroke patients

Scientific Title:Acronym

Prevention of pneumonia

Region

Japan


Condition

Condition

stroke

Classification by specialty

Neurology Rehabilitation medicine Nursing
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The actual incidence of pneumonia in our hospital has been suggested in a previous study that National Institutes of Health Stroke Scale scores of 12 or higher may be a high-risk population for developing pneumonia, and the time to develop pneumonia after stroke was within 7days in 75% of patients . In light of these results, it is essential to investigate whether nursing care can prevent the development of pneumonia.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of pneumonia from day of admission to day 8 of hospitalization

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

The method of positioning is to perform two sets of forward leaning side lying position for at least 30 minutes and no more than 180 minutes on each side per day for 7 days after admission.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Stroke patients, excluding subarachnoid hemorrhage, who are admitted to our neurology department and have a NIHSS score of 12 or higher at the time of admission

Key exclusion criteria

Patients who are deemed by the attending physician to be unable to participate in the study, such as those who have undergone craniotomy and have had their skull removed.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Satomi
Middle name
Last name Miyanosita

Organization

Saga University Hospital

Division name

nursing department

Zip code

8498501

Address

5-1-1 Nabeshima, Saga City, Saga Prefecture

TEL

0952316511

Email

f9774@cc.saga-u.ac.jp


Public contact

Name of contact person

1st name Yumi
Middle name
Last name Konishi

Organization

nursing department

Division name

Brain Nerve Center

Zip code

8498501

Address

5-1-1 Nabeshima, Saga City, Saga Prefecture

TEL

0952316511

Homepage URL


Email

f9774@cc.saga-u.ac.jp


Sponsor or person

Institute

National Institute of Biomedical Research and Innovation (NIBIO)

Institute

Department

Personal name



Funding Source

Organization

National Institute of Biomedical Research and Innovation (NIBIO)

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Center, Saga University Hospital

Address

5-1-1 Nabeshima, Saga City, Saga Prefecture

Tel

0952343400

Email

f9774@cc.saga-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2023 Year 04 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 04 Month 13 Day

Last modified on

2023 Year 10 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000052335


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name